Legend Biotech Co. (NASDAQ:LEGN) Receives $81.22 Consensus Price Target from Brokerages
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has been assigned an average rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the stock in […]
More Stories
Analysts Set WEBTOON Entertainment Inc. (NASDAQ:WBTN) Target Price at $27.17
WEBTOON Entertainment Inc. (NASDAQ:WBTN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six...
Brunswick Co. (NYSE:BC) Director Joseph W. Mcclanathan Sells 4,745 Shares
Brunswick Co. (NYSE:BC – Get Free Report) Director Joseph W. Mcclanathan sold 4,745 shares of the business’s stock in a...
Kelly Lynn Loeffler Buys 1,203,704 Shares of PSQ Holdings, Inc. (NYSE:PSQH) Stock
PSQ Holdings, Inc. (NYSE:PSQH – Get Free Report) Director Kelly Lynn Loeffler purchased 1,203,704 shares of the business’s stock in...
Manhattan Associates, Inc. (NASDAQ:MANH) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Manhattan Associates, Inc. (NASDAQ:MANH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from...
Brokerages Set Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) Target Price at $80.88
Shares of Coca-Cola Europacific Partners PLC (NASDAQ:CCEP – Get Free Report) have been assigned an average recommendation of “Buy” from...
StockNews.com Initiates Coverage on U.S. Global Investors (NASDAQ:GROW)
StockNews.com initiated coverage on shares of U.S. Global Investors (NASDAQ:GROW – Free Report) in a research report released on Sunday...